Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia.
作者： Subrata Mandal , Pradeep Venkatesh , Zahir Abbas , Rajpal Vohra , Satpal Garg
DOI: 10.1007/S00417-007-0567-8
关键词:
摘要: Background To evaluate the efficacy and safety of intravitreal bevacizumab (Avastin) in treatment subretinal neovascularization (SRNV) secondary to type 2A idiopathic juxtafoveal telangiectasia (IJT).
springer.com
sci-hub.se 参考文章(16)
J S Duker, E Reichel, P A Yates, A H Rogers, I Yamamoto, INTRAVITREAL BEVACIZUMAB (AVASTIN) AS TREATMENT FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA Investigative Ophthalmology & Visual Science. ,vol. 91, pp. 157- 160 ,(2006)
Lelia A. Paunescu, Tony H. Ko, Jay S. Duker, Annie Chan, Wolfgang Drexler, Joel S. Schuman, James G. Fujimoto, Idiopathic juxtafoveal retinal telangiectasis: New findings by ultrahigh-resolution optical coherence tomography Ophthalmology. ,vol. 113, pp. 48- 57 ,(2006) , 10.1016/J.OPHTHA.2005.08.016
MaheshP Shanmugam, Manisha Agarwal, RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis. Indian Journal of Ophthalmology. ,vol. 53, pp. 61- 63 ,(2005) , 10.4103/0301-4738.15289
Bernadette Snyers, Claire Verougstraete, Laurence Postelmans, Anita Leys, Philip Hykin, Photodynamic therapy of subfoveal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis American Journal of Ophthalmology. ,vol. 137, pp. 812- 819 ,(2004) , 10.1016/J.AJO.2003.11.076
Lindsay M. Smithen, Richard F. Spaide, Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis American Journal of Ophthalmology. ,vol. 138, pp. 884- 885 ,(2004) , 10.1016/J.AJO.2004.05.073
J. D. Gass, R. T. Oyakawa, Idiopathic juxtafoveolar retinal telangiectasis Archives of Ophthalmology. ,vol. 100, pp. 769- 780 ,(1982) , 10.1001/ARCHOPHT.1982.01030030773010
ADAM S. BERGER, BROOKS W. MCCUEN, GARY C. BROWN, ROBERT L. BROWNLOW, Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina-the Journal of Retinal and Vitreous Diseases. ,vol. 17, pp. 94- 98 ,(1997) , 10.1097/00006982-199703000-00002
Ziad F. Bashshur, Ali Bazarbachi, Alexandre Schakal, Zeina A. Haddad, Christelle P. El Haibi, Baha’ N. Noureddin, Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. American Journal of Ophthalmology. ,vol. 142, pp. 1- 9 ,(2006) , 10.1016/J.AJO.2006.02.037
Robert L. Avery, Dante J. Pieramici, Melvin D. Rabena, Alessandro A. Castellarin, Ma’an A. Nasir, Matthew J. Giust, Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. ,vol. 113, pp. 363- 372 ,(2006) , 10.1016/J.OPHTHA.2005.11.019
Rodrigo Jorge, Rogério A. Costa, Daniela Calucci, Ingrid U. Scott, Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 245, pp. 1045- 1048 ,(2007) , 10.1007/S00417-006-0468-2